# Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus

> **NCT00626717** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 30 (actual)

## Conditions studied

- Keratoconus

## Interventions

- **PROCEDURE:** Riboflavin/UVA crosslinking
- **PROCEDURE:** Sham treatment

## Key facts

- **NCT ID:** NCT00626717
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626717, "Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00626717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*